Thursday, April 28, 2011 12:51:20 PM
http://www.newfield.com/history.aspx
US: Newfield says its South Texas Eagle Ford fields yielding oil
Oil and gas producer Newfield Exploration said Monday that a months-long drilling program to assess its south Texas oil fields has confirmed that its 335,000 acres there sit within an oil-rich portion of the Eagle Ford shale formation. 'All of our initial Eagle Ford assessment wells found light oil and confirmed an active petroleum system and producible oil and gas across a vast area,' Chief Executive Lee K. Boothby said in a news release.
Houston-based Newfield acquired the acreage from bankrupt TXCO Resources in February as part of a joint acquisition with Anadarko Petroleum. Newfield executives have estimated that the company paid about $400 per acre once the value of producing wells was discounted.
The company drilled 11 wells in the so-called Maverick Basin. Peak daily production ranged between the equivalent of 400 and 900 barrels of oil, Newfield said Monday. In addition to examining the fields' production potential, wells were drilled to satisfy lease obligations, the company said. The company said it plans to continue to drill with at least two rigs to meet lease requirements.Newfield will 'substantially increase' investment in the area in the second half of this year, Boothby said.
Source: Dow Jones Newswires
Recent NFX News
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/19/2024 02:39:02 PM
- Nuformix announces subscription to raise GBP150,000 • Alliance News • 03/01/2024 10:31:01 AM
- Nuformix PLC Subscription to raise £150,000 • RNS Regulatory News • 03/01/2024 07:00:04 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • UK Regulatory • 01/15/2024 11:30:00 AM
- Nuformix narrows annual loss as develops drug assets • Alliance News • 01/03/2024 10:16:07 AM
- Nuformix PLC Results for the period ended 30 September 2023 • UK Regulatory • 01/03/2024 07:00:00 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 12/18/2023 07:00:00 AM
- Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 • Alliance News • 10/23/2023 11:38:39 AM
- Nuformix PLC Notice of Allowance of NXP002 Patent in Japan • UK Regulatory • 10/23/2023 06:04:00 AM
- Nuformix to receive milestone payments from Oxilio pact • Alliance News • 09/18/2023 09:20:54 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 09/18/2023 06:00:00 AM
- Nuformix PLC Result of Annual General Meeting • UK Regulatory • 08/24/2023 12:22:00 PM
- Nuformix PLC Notice of AGM • UK Regulatory • 07/31/2023 01:00:00 PM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 07/26/2023 01:55:00 PM
- Nuformix PLC Investor Online Q&A • RNS Non-Regulatory • 06/02/2023 06:00:00 AM
- Nuformix PLC Change of Auditor • UK Regulatory • 05/25/2023 06:00:00 AM
- Nuformix loss narrows; near-term goal to focus on NXP002 asset • Alliance News • 05/22/2023 11:45:14 AM
- Nuformix PLC Unaudited Interim Report • UK Regulatory • 05/22/2023 06:00:00 AM
- Nuformix says NXP002 shows anti-inflammatory effect • Alliance News • 05/18/2023 01:31:17 PM
- Nuformix PLC NXP002 Inflammation and Duration of Action Update • UK Regulatory • 05/18/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM